Efficacy of Platelet-Rich Plasma Versus Placebo for the Treatment of Greater Trochanteric Pain Syndrome
Journal of Bone and Joint Surgery · 2025
DOI: 10.2106/jbjs.24.00763 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Bone and Joint Surgery, 2025. Verfasst von Ismael Atchia und 4 weiteren Autor:innen. Beteiligte Einrichtung: Northumbria Healthcare NHS Foundation Trust, Northumberland, United Kingdom. Hauptthemen laut MEDLINE: Platelet-Rich Plasma, Tendinopathy, Bursitis. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 36 Literaturangaben.
Abstract (Originalsprache)
Background
Greater trochanteric pain syndrome (GTPS) is a painful condition that can impair a patient’s quality of life. If nonoperative measures fail, progressively more invasive treatment options may be required. This clinical trial aimed to evaluate the effectiveness of ultrasound-guided leukocyte-rich platelet-rich plasma (LR-PRP) injections in the treatment of refractory GTPS caused by bursitis and/or gluteal tendinopathy.
Methods
An ethically approved, adequately powered, double-blinded randomized controlled trial (RCT) was conducted to evaluate the clinical outcomes in randomized LR-PRP and placebo groups using the International Hip Outcome Tool-12 (iHOT-12), a visual analogue scale (VAS) for pain, the modified Harris hip score (mHHS), the EuroQol 5-Dimensions (EQ-5D) questionnaire, and the presence or absence of complications. All injections were performed under ultrasound guidance into the trochanteric bursa and gluteus medius tendon.
Results
The final analysis included 79 patients (39 in the LR-PRP and 40 in the placebo group; 73 female and 6 male; all Caucasian). Both the LR-PRP and the placebo group generally had improvement from baseline that was maintained to 12 months. The only deterioration in scores compared to baseline was seen in the LR-PRP group for the iHOT-12 at 12 months, the EQ-5D index at 3 and 6 months, and the EQ-5D VAS at all follow-up time points. However, there was no significant difference between the 2 groups at any follow-up point (p > 0.05). A multivariable linear regression model, with adjustment for age, sex, body mass index, and preoperative baseline score, did not reveal any significant associations between iHOT-12 and EQ-5D score gains at 12 months and treatment.
Conclusions
This randomized trial found no significant difference in outcomes between LR-PRP and placebo for the treatment of greater trochanteric pain up to 6 months following the intervention. As a result, we do not support the routine use of PRP for the treatment of this condition. Level of Evidence: Therapeutic Level I . See Instructions for Authors for a complete description of levels of evidence.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Northumbria Healthcare NHS Foundation Trust, Northumberland, United Kingdom.
- Newcastle University, Newcastle upon Tyne, United Kingdom.
- Health Education North East England, Newcastle upon Tyne, United Kingdom.
- Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom.
- Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, United Kingdom.
- School of Medicine, University of Sunderland, Sunderland, United Kingdom.
ORCID-Profile: Ismael Atchia, Mohammed Ali, Eshan Oderuth, Richard Holleyman, Ajay Malviya
Zitieren
APA
Atchia, I., Ali, M., Oderuth, E., Holleyman, R., & Malviya, A. (2025). Efficacy of Platelet-Rich Plasma Versus Placebo for the Treatment of Greater Trochanteric Pain Syndrome. Journal of Bone and Joint Surgery. https://doi.org/10.2106/jbjs.24.00763
Vancouver
Atchia I, Ali M, Oderuth E, Holleyman R, Malviya A. Efficacy of Platelet-Rich Plasma Versus Placebo for the Treatment of Greater Trochanteric Pain Syndrome. Journal of Bone and Joint Surgery. 2025. doi:10.2106/jbjs.24.00763
BibTeX
@article{Atchia2025,
author = {Atchia, Ismael and Ali, Mohammed and Oderuth, Eshan and Holleyman, Richard and Malviya, Ajay},
title = {Efficacy of Platelet-Rich Plasma Versus Placebo for the Treatment of Greater Trochanteric Pain Syndrome},
journal = {Journal of Bone and Joint Surgery},
year = {2025},
doi = {10.2106/jbjs.24.00763}
}
EUVIMED